Potentiation of the in vitro Antistaphylococcal Effect of Oxacillin and Tetracycline by the Anti-Inflammatory Drug Diacetyl Rhein
- 1 January 2013
- journal article
- research article
- Published by S. Karger AG in Chemotherapy
- Vol. 59 (6) , 447-452
Abstract
Background: The anti-inflammatory drug diacetyl rhein has been found to possess promising antistaphylococcal effects against various drug-resistant strains in our previous study. In the present work, we explored the in vitro combinatory interactions of diacetyl rhein with oxacillin and tetracycline against 13 standard strains and clinical isolates of Staphylococcus aureus, including those resistant to erythromycin, methicillin and tetracycline. Methods: Minimum inhibitory concentrations were determined by broth microdilution assay, and the effects of combinations were evaluated according to the sum of fractional inhibitory concentrations (ΣFICs). Results: Synergistic or additive effects were observed against all S. aureus strains (ΣFIC 0.258-1), whereas diacetyl rhein-oxacillin appeared to be the most effective combination, synergistically inhibiting the growth of 4 strains tested. Conclusion: To our best knowledge, this is the first report on a synergistic antibacterial effect of diacetyl rhein. Our results suggest this promising compound for further evaluation of its synergistic anti-infective potential as an agent with a combined anti-inflammatory and synergistic antibacterial action.Keywords
This publication has 24 references indexed in Scilit:
- Microbial Efflux Systems and Inhibitors: Approaches to Drug Discovery and the Challenge of Clinical ImplementationThe Open Microbiology Journal, 2013
- Recent Advances in Multi-Drug Resistance (MDR) Efflux Pump Inhibitors of Gram-Positive Bacteria S. aureusAntibiotics, 2013
- In Vitro Interactions between Aspirin and Amphotericin B against Planktonic Cells and Biofilm Cells of Candida albicans and C. parapsilosisAntimicrobial Agents and Chemotherapy, 2012
- Synergistic effect of rhein in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureusExperimental and Therapeutic Medicine, 2012
- Septic arthritisBest Practice & Research Clinical Rheumatology, 2011
- The continuing crisis in antibiotic resistanceInternational Journal of Antimicrobial Agents, 2010
- Effects of diacerein at the molecular level in the osteoarthritis disease processTherapeutic Advances in Musculoskeletal Disease, 2010
- The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug targetEuropean Journal of Clinical Microbiology & Infectious Diseases, 2009
- Multidrug Pump Inhibitors Uncover Remarkable Activity of Plant AntimicrobialsAntimicrobial Agents and Chemotherapy, 2002
- Metabolism of Sennosides and Rhein in the RatPharmacology, 1980